Human Gene MIR130A (uc001nku.1) Description and Page Index
  Description: Homo sapiens microRNA 130a (MIR130A), microRNA.
RefSeq Summary (NR_029673): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript is intronless :: LM608488.1 [ECO:0000345] ##Evidence-Data-END##
Transcript (Including UTRs)
   Position: hg19 chr11:57,408,671-57,408,759 Size: 89 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksCTDRNA-Seq ExpressionMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-15

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:57,408,671-57,408,759)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerHGNCLynxOMIM
PubMedStanford SOURCE

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  LF205743 - JP 2014500723-A/13246: Polycomb-Associated Non-Coding RNAs.
MA441320 - JP 2018138019-A/13246: Polycomb-Associated Non-Coding RNAs.
CS266399 - Sequence 91 from Patent WO2005118806.
DL076561 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004211 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM175377 - A nucleics Acid regulating cell growth.
FU261168 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763670 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV527571 - Nucleic acid controling mast cell degranulation.
FW421553 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FZ435766 - JP 2011501949-A/83: DIAGNOSIS AND PROGNOSIS OF SPECIFIC CANCERS.
HH826060 - Sequence 13 from Patent WO2010100328.
HV304569 - JP 2009531018-A/136: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305067 - JP 2009531019-A/136: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV444498 - JP 2011515078-A/30: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS.
HW101981 - JP 2013500034-A/108: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119276 - JP 2013046612-A/136: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367424 - JP 2012228254-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411817 - JP 2014000079-A/91: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589605 - JP 2013121348-A/136: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674163 - JP 2014217381-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ043264 - JP 2015510401-A/354: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067105 - JP 2014012020-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081890 - JP 2015514392-A/354: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408270 - JP 2015528002-A/867: CHIRAL CONTROL.
HZ413409 - JP 2014060993-A/136: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427529 - JP 2014217384-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428332 - JP 2014217385-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429135 - JP 2014217386-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429938 - JP 2014217387-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501620 - JP 2016025853-A/136: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769195 - JP 2014223080-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058589 - Sequence 91 from Patent EP2298893.
JA059392 - Sequence 91 from Patent EP2298894.
JA073715 - Sequence 91 from Patent EP2281887.
JA104852 - Sequence 91 from Patent EP2302051.
JA106192 - Sequence 91 from Patent EP2302052.
JA106995 - Sequence 91 from Patent EP2302053.
JA107798 - Sequence 91 from Patent EP2302054.
JA108601 - Sequence 91 from Patent EP2302055.
JA109404 - Sequence 91 from Patent EP2302056.
JA187232 - Sequence 1 from Patent WO2011018506.
JA191920 - Sequence 91 from Patent EP2290066.
JA192819 - Sequence 91 from Patent EP2290067.
JA193718 - Sequence 91 from Patent EP2290068.
JA194617 - Sequence 91 from Patent EP2290069.
JA195516 - Sequence 91 from Patent EP2290070.
JA196415 - Sequence 91 from Patent EP2290071.
JA197314 - Sequence 91 from Patent EP2290072.
JA198213 - Sequence 91 from Patent EP2290073.
JA199112 - Sequence 91 from Patent EP2290074.
JA200011 - Sequence 91 from Patent EP2290075.
JA200910 - Sequence 91 from Patent EP2290076.
JA218032 - Sequence 91 from Patent EP2281888.
JA226183 - Sequence 91 from Patent EP2292755.
JA229038 - Sequence 91 from Patent EP2292756.
JA254165 - Sequence 1 from Patent EP2283846.
JA257309 - Sequence 91 from Patent EP2284265.
JA278589 - Sequence 91 from Patent EP2281886.
JA284475 - Sequence 91 from Patent EP2281889.
JA292528 - Sequence 91 from Patent EP2287303.
JA317714 - Sequence 91 from Patent EP2314688.
JA374773 - Sequence 91 from Patent EP2322616.
JA525986 - Sequence 136 from Patent EP2369011.
JA526493 - Sequence 136 from Patent EP2369012.
JA527000 - Sequence 136 from Patent EP2369013.
JA535929 - Sequence 136 from Patent EP2371971.
JA787934 - Sequence 136 from Patent EP2479285.
JA788432 - Sequence 136 from Patent EP2479286.
JA810766 - Sequence 136 from Patent EP2468890.
JA811264 - Sequence 136 from Patent EP2468891.
JA811762 - Sequence 136 from Patent EP2468893.
JA812260 - Sequence 136 from Patent EP2468894.
JA812758 - Sequence 136 from Patent EP2468895.
JA813256 - Sequence 136 from Patent EP2468896.
JA813754 - Sequence 136 from Patent EP2468897.
JA814252 - Sequence 136 from Patent EP2468898.
JA814750 - Sequence 136 from Patent EP2468899.
JA816993 - Sequence 136 from Patent EP2468892.
JA825805 - Sequence 136 from Patent EP2471956.
JA826303 - Sequence 136 from Patent EP2471958.
JB024590 - Sequence 136 from Patent EP2505668.
JB025088 - Sequence 136 from Patent EP2505669.
JB079475 - Sequence 136 from Patent EP2487252.
JB079973 - Sequence 136 from Patent EP2487253.
JB080471 - Sequence 136 from Patent EP2487254.
JB080969 - Sequence 136 from Patent EP2487255.
JB081467 - Sequence 136 from Patent EP2487256.
JB081965 - Sequence 136 from Patent EP2487257.
JB082463 - Sequence 136 from Patent EP2487258.
JB082961 - Sequence 136 from Patent EP2487259.
JB083459 - Sequence 136 from Patent EP2487260.
JB083957 - Sequence 136 from Patent EP2487261.
JB084455 - Sequence 136 from Patent EP2487262.
JB084953 - Sequence 136 from Patent EP2487263.
JB087631 - Sequence 136 from Patent EP2502630.
JB147835 - Sequence 136 from Patent EP2484782.
JB148333 - Sequence 136 from Patent EP2484783.
JB153058 - Sequence 136 from Patent EP2514433.
JB153556 - Sequence 136 from Patent EP2514434.
JB622145 - Sequence 136 from Patent EP2586454.
JB622643 - Sequence 136 from Patent EP2586455.
JC001706 - Sequence 136 from Patent EP2591794.
JC037552 - Sequence 80 from Patent EP2643479.
JC221616 - Sequence 91 from Patent EP2471923.
JC268182 - Sequence 91 from Patent EP2471924.
JC340490 - Sequence 91 from Patent EP2471922.
JC469736 - Sequence 91 from Patent EP2471921.
JC990525 - Sequence 91 from Patent EP2808390.
LF404361 - JP 2015509366-A/354: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF714628 - JP 2016165292-A/91: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856562 - JP 2015142597-A/91: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051604 - KR 1020150036642-A/870: CHIRAL CONTROL.
MA353892 - JP 2018075017-A/354: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
CS266589 - Sequence 281 from Patent WO2005118806.
DL076751 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004401 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421743 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367614 - JP 2012228254-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW412007 - JP 2014000079-A/281: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674353 - JP 2014217381-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067295 - JP 2014012020-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427719 - JP 2014217384-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428522 - JP 2014217385-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429325 - JP 2014217386-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430128 - JP 2014217387-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769385 - JP 2014223080-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058779 - Sequence 281 from Patent EP2298893.
JA059582 - Sequence 281 from Patent EP2298894.
JA073905 - Sequence 281 from Patent EP2281887.
JA105042 - Sequence 281 from Patent EP2302051.
JA106382 - Sequence 281 from Patent EP2302052.
JA107185 - Sequence 281 from Patent EP2302053.
JA107988 - Sequence 281 from Patent EP2302054.
JA108791 - Sequence 281 from Patent EP2302055.
JA109594 - Sequence 281 from Patent EP2302056.
JA192110 - Sequence 281 from Patent EP2290066.
JA193009 - Sequence 281 from Patent EP2290067.
JA193908 - Sequence 281 from Patent EP2290068.
JA194807 - Sequence 281 from Patent EP2290069.
JA195706 - Sequence 281 from Patent EP2290070.
JA196605 - Sequence 281 from Patent EP2290071.
JA197504 - Sequence 281 from Patent EP2290072.
JA198403 - Sequence 281 from Patent EP2290073.
JA199302 - Sequence 281 from Patent EP2290074.
JA200201 - Sequence 281 from Patent EP2290075.
JA201100 - Sequence 281 from Patent EP2290076.
JA218222 - Sequence 281 from Patent EP2281888.
JA226373 - Sequence 281 from Patent EP2292755.
JA229228 - Sequence 281 from Patent EP2292756.
JA257499 - Sequence 281 from Patent EP2284265.
JA278779 - Sequence 281 from Patent EP2281886.
JA284665 - Sequence 281 from Patent EP2281889.
JA292718 - Sequence 281 from Patent EP2287303.
JA317904 - Sequence 281 from Patent EP2314688.
JA374963 - Sequence 281 from Patent EP2322616.
JC221806 - Sequence 281 from Patent EP2471923.
JC268372 - Sequence 281 from Patent EP2471924.
JC340680 - Sequence 281 from Patent EP2471922.
JC469926 - Sequence 281 from Patent EP2471921.
JC990715 - Sequence 281 from Patent EP2808390.
LF714818 - JP 2016165292-A/281: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856752 - JP 2015142597-A/281: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
MS816696 - Sequence 45 from Patent WO2017085287.
FV525742 - Nucleic acid controling mast cell degranulation.
FW363992 - Oligonucleotides for modulating target RNA activity.
HI560915 - Sequence 130 from Patent EP2190992.
HI965462 - Sequence 747 from Patent WO2010139812.
HI965848 - Sequence 168 from Patent WO2010139811.
HI966714 - Sequence 168 from Patent WO2010139810.
HV594016 - JP 2010538653-A/130: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594871 - JP 2010539959-A/252: Micromirs.
HW101929 - JP 2013500034-A/56: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HZ074084 - JP 2013535982-A/175: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157428 - JP 2015130862-A/252: Micromirs.
HZ186305 - JP 2015146814-A/54: Oligonucleotides for modulating target RNA activity.
HZ479775 - JP 2015535430-A/281: TERMINALLY MODIFIED RNA.
HZ789706 - JP 2016504050-A/1451: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287374 - Sequence 56 from Patent WO2011015720.
JA401500 - Sequence 747 from Patent WO2011080318.
JA402478 - Sequence 747 from Patent WO2011080315.
JA403485 - Sequence 747 from Patent WO2011080316.
JA406116 - Sequence 747 from Patent EP2336353.
JA426989 - Sequence 322 from Patent WO2011072177.
JA429642 - Sequence 747 from Patent WO2011095623.
JA791619 - Sequence 21 from Patent WO2012089772.
JB074933 - Sequence 193 from Patent WO2012168448.
JB175272 - Sequence 304 from Patent WO2012101219.
JB620260 - Sequence 240 from Patent WO2013063544.
JB624310 - Sequence 130 from Patent EP2610342.
JC017573 - Sequence 11 from Patent WO2013093870.
JC244473 - Sequence 93 from Patent WO2012020308.
JC512438 - Sequence 2691 from Patent WO2014113089.
LF161824 - JP 2016513950-A/1890: Oligomers with improved off-target profile.
LF401867 - JP 2015502976-A/11: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LP726474 - Sequence 168 from Patent EP2883966.
LP818744 - Sequence 168 from Patent EP3296406.
LP938686 - Sequence 168 from Patent EP3184651.
LQ070026 - Sequence 350 from Patent EP2964234.
LQ441186 - Sequence 193 from Patent EP3029157.
LQ724937 - Sequence 570 from Patent WO2018096084.
LY404936 - KR 1020160117535-A/241: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ231624 - JP 2017186339-A/11: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233662 - JP 2017184756-A/54: Oligonucleotides for modulating target RNA activity.
MA260175 - JP 2017505623-A/241: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS833425 - Sequence 130 from Patent EP3112464.
MS834601 - Sequence 747 from Patent EP3112479.
CQ873651 - Sequence 70 from Patent WO2004076622.
DD413488 - Regulation of Mammalian Cells.
DJ003751 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027030 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
FU261415 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763917 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304816 - JP 2009531018-A/383: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305314 - JP 2009531019-A/383: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119523 - JP 2013046612-A/383: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589852 - JP 2013121348-A/383: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413656 - JP 2014060993-A/383: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501867 - JP 2016025853-A/383: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526233 - Sequence 383 from Patent EP2369011.
JA526740 - Sequence 383 from Patent EP2369012.
JA527247 - Sequence 383 from Patent EP2369013.
JA536176 - Sequence 383 from Patent EP2371971.
JA788181 - Sequence 383 from Patent EP2479285.
JA788679 - Sequence 383 from Patent EP2479286.
JA811013 - Sequence 383 from Patent EP2468890.
JA811511 - Sequence 383 from Patent EP2468891.
JA812009 - Sequence 383 from Patent EP2468893.
JA812507 - Sequence 383 from Patent EP2468894.
JA813005 - Sequence 383 from Patent EP2468895.
JA813503 - Sequence 383 from Patent EP2468896.
JA814001 - Sequence 383 from Patent EP2468897.
JA814499 - Sequence 383 from Patent EP2468898.
JA814997 - Sequence 383 from Patent EP2468899.
JA817240 - Sequence 383 from Patent EP2468892.
JA826052 - Sequence 383 from Patent EP2471956.
JA826550 - Sequence 383 from Patent EP2471958.
JB024837 - Sequence 383 from Patent EP2505668.
JB025335 - Sequence 383 from Patent EP2505669.
JB079722 - Sequence 383 from Patent EP2487252.
JB080220 - Sequence 383 from Patent EP2487253.
JB080718 - Sequence 383 from Patent EP2487254.
JB081216 - Sequence 383 from Patent EP2487255.
JB081714 - Sequence 383 from Patent EP2487256.
JB082212 - Sequence 383 from Patent EP2487257.
JB082710 - Sequence 383 from Patent EP2487258.
JB083208 - Sequence 383 from Patent EP2487259.
JB083706 - Sequence 383 from Patent EP2487260.
JB084204 - Sequence 383 from Patent EP2487261.
JB084702 - Sequence 383 from Patent EP2487262.
JB085200 - Sequence 383 from Patent EP2487263.
JB087878 - Sequence 383 from Patent EP2502630.
JB148082 - Sequence 383 from Patent EP2484782.
JB148580 - Sequence 383 from Patent EP2484783.
JB153305 - Sequence 383 from Patent EP2514433.
JB153803 - Sequence 383 from Patent EP2514434.
JB622392 - Sequence 383 from Patent EP2586454.
JB622890 - Sequence 383 from Patent EP2586455.
JC001953 - Sequence 383 from Patent EP2591794.
CS447664 - Sequence 10 from Patent WO2006108718.
CS548267 - Sequence 1297 from Patent EP1777301.
DJ087826 - Novel miRNA molecules isolated from human embryonic stem cell.
DJ442927 - METHOD FOR DETECTING ncRNA.
DM174433 - A nucleics Acid regulating cell growth.
FV527952 - Nucleic acid controling mast cell degranulation.
FW312007 - DETECTING NUCLEIC ACIDS.
FW363991 - Oligonucleotides for modulating target RNA activity.
FZ413568 - WO 2011001906-A/41: Method for evaluation of cultured cells.
FZ414413 - WO 2011007815-A/303: A method for screening a food which promotes production of milk having immunoregulating effect.
FZ435751 - JP 2011501949-A/68: DIAGNOSIS AND PROGNOSIS OF SPECIFIC CANCERS.
HH826080 - Sequence 33 from Patent WO2010100328.
HI560914 - Sequence 129 from Patent EP2190992.
HI965463 - Sequence 748 from Patent WO2010139812.
HI966514 - Sequence 834 from Patent WO2010139811.
HI967380 - Sequence 834 from Patent WO2010139810.
HV444538 - JP 2011515078-A/70: TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS.
HV594015 - JP 2010538653-A/129: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594870 - JP 2010539959-A/251: Micromirs.
HV821941 - JP 2011140513-A/303: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV950092 - WO 2012121178-A/15: Tumor Angiogenesis Inhibitor.
HV953901 - JP 2012518421-A/813: METHODS OF DETECTING LUNG CANCER.
HW101877 - JP 2013500034-A/4: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW289784 - JP 2013520158-A/27: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HW523292 - JP 2014507123-A/77: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW913352 - JP 2015504307-A/112: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ043152 - JP 2015510401-A/242: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043411 - JP 2015510401-A/501: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074085 - JP 2013535982-A/176: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081778 - JP 2015514392-A/242: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082756 - JP 2015513906-A/113: Stem Cell Microparticles.
HZ157427 - JP 2015130862-A/251: Micromirs.
HZ186304 - JP 2015146814-A/53: Oligonucleotides for modulating target RNA activity.
HZ392521 - JP 2015180203-A/27: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HZ436537 - JP 2015529450-A/113: Stem Cell Microparticles.
HZ479774 - JP 2015535430-A/280: TERMINALLY MODIFIED RNA.
HZ789705 - JP 2016504050-A/1450: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA187233 - Sequence 2 from Patent WO2011018506.
JA254166 - Sequence 2 from Patent EP2283846.
JA287201 - Sequence 3 from Patent WO2011017697.
JA287322 - Sequence 4 from Patent WO2011015720.
JA401501 - Sequence 748 from Patent WO2011080318.
JA402479 - Sequence 748 from Patent WO2011080315.
JA403486 - Sequence 748 from Patent WO2011080316.
JA406117 - Sequence 748 from Patent EP2336353.
JA427308 - Sequence 641 from Patent WO2011072177.
JA429643 - Sequence 748 from Patent WO2011095623.
JA682594 - Sequence 62 from Patent WO2011149354.
JA715031 - Sequence 813 from Patent EP2401406.
JA791746 - Sequence 148 from Patent WO2012089772.
JA885447 - Sequence 77 from Patent WO2012083004.
JB022718 - Sequence 560 from Patent WO2013026685.
JB050188 - Sequence 275 from Patent WO2013020926.
JB075028 - Sequence 288 from Patent WO2012168448.
JB149228 - Sequence 303 from Patent EP2455486.
JB175001 - Sequence 33 from Patent WO2012101219.
JB235885 - Sequence 41 from Patent EP2450454.
JB406725 - Sequence 51 from Patent WO2012072685.
JB620261 - Sequence 241 from Patent WO2013063544.
JB624309 - Sequence 129 from Patent EP2610342.
JB778733 - Sequence 112 from Patent WO2013078283.
JB835769 - Sequence 59 from Patent WO2013057567.
JC019974 - Sequence 41 from Patent EP2644706.
JC032768 - Sequence 40 from Patent WO2013160474.
JC037482 - Sequence 10 from Patent EP2643479.
JC171741 - Sequence 113 from Patent WO2013150303.
JC244474 - Sequence 94 from Patent WO2012020308.
JC334110 - Sequence 28 from Patent EP2487240.
JC512437 - Sequence 2690 from Patent WO2014113089.
JC572552 - Sequence 113 from Patent WO2014125276.
JC582240 - Sequence 113 from Patent WO2014125277.
JE844294 - Sequence 37 from Patent WO2015091897.
JE953936 - Sequence 113 from Patent WO2015052526.
JE955689 - Sequence 113 from Patent WO2015052527.
LF137441 - JP 2016507550-A/113: Method of Producing Microparticles.
LF160958 - JP 2016513950-A/1024: Oligomers with improved off-target profile.
LF162406 - JP 2016513095-A/113: Stem Cell Microparticles and miRNA.
LF404249 - JP 2015509366-A/242: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF404481 - JP 2015509366-A/474: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF636332 - JP 2016519076-A/106: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953158 - JP 2016534103-A/113: Stem Cell Microparticles and miRNA.
LG005503 - KR 1020150004822-A/113: STEM CELL MICROPARTICLES.
LG053199 - KR 1020150059168-A/113: STEM CELL MICROPARTICLES.
LG134489 - KR 1020150131312-A/107: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240438 - KR 1020160035087-A/113: STEM CELL MICROPARTICLES AND MIRNA.
LP727140 - Sequence 834 from Patent EP2883966.
LP740421 - Sequence 4 from Patent EP3298182.
LP782008 - Sequence 13 from Patent WO2018055093.
LP819410 - Sequence 834 from Patent EP3296406.
LP844606 - Sequence 7 from Patent EP3198013.
LP871150 - Sequence 8 from Patent EP3254683.
LP917459 - Sequence 55 from Patent WO2017153710.
LP939352 - Sequence 834 from Patent EP3184651.
LP951539 - Sequence 45 from Patent WO2017157650.
LP958368 - Sequence 8 from Patent WO2017211617.
LQ070025 - Sequence 349 from Patent EP2964234.
LQ278699 - Sequence 238 from Patent WO2016066288.
LQ420440 - Sequence 16 from Patent WO2016127998.
LQ422068 - Sequence 6 from Patent EP3026121.
LQ441281 - Sequence 288 from Patent EP3029157.
LQ844135 - Sequence 55 from Patent WO2018138468.
LV470523 - JP 2016534036-A/113: Stem Cell Microparticles and miRNA.
LV539172 - JP 2016539127-A/173: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LY298574 - KR 1020160079824-A/173: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY404935 - KR 1020160117535-A/240: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504718 - KR 1020170035932-A/107: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233661 - JP 2017184756-A/53: Oligonucleotides for modulating target RNA activity.
LZ242999 - JP 2017525350-A/107: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260174 - JP 2017505623-A/240: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA353780 - JP 2018075017-A/242: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA354012 - JP 2018075017-A/474: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS833424 - Sequence 129 from Patent EP3112464.
MS834602 - Sequence 748 from Patent EP3112479.
MS902087 - Sequence 560 from Patent EP3156505.
MS944851 - Sequence 107 from Patent EP3177739.
MA643527 - JP 2017113010-A/1451: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731411 - JP 2017140048-A/281: TERMINALLY MODIFIED RNA.
MA643526 - JP 2017113010-A/1450: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731410 - JP 2017140048-A/280: TERMINALLY MODIFIED RNA.
MA784272 - JP 2018524972-A/4: Methods and Compositions for Diagnosing or Detecting Lung Cancers.
MA406379 - JP 2018518147-A/9: Detection of Brain Injury.
MA405526 - WO 2018155427-A/300: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA406414 - JP 2018518147-A/44: Detection of Brain Injury.
MP045532 - Sequence 354 from Patent EP3401394.
MP084202 - Sequence 354 from Patent EP3401393.
MP014834 - Sequence 37 from Patent WO2019016252.
MP045420 - Sequence 242 from Patent EP3401394.
MP045652 - Sequence 474 from Patent EP3401394.
MP084090 - Sequence 242 from Patent EP3401393.
MA800580 - JP 2018183181-A/1451: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800579 - JP 2018183181-A/1450: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129213 - Sequence 113 from Patent EP3470073.
MP162136 - Sequence 113 from Patent WO2019069093.
MB018387 - JP 2018504915-A/16: A microRNA-based method for early detection of prostate cancer in urine samples.
MP272080 - Sequence 28 from Patent WO2019157381.
MP280588 - Sequence 8 from Patent WO2019111197.
MP283501 - Sequence 8 from Patent WO2019111198.
LY579340 - KR 1020180009762-A/4: METHODS AND COMPOSITIONS FOR DIAGNOSING OR DETECTING LUNG CANCERS.
MB119553 - WO 2019117257-A/75: Method of aiding detection of breast cancer.
MB119552 - WO 2019117257-A/74: Method of aiding detection of breast cancer.
MB119770 - WO 2019117269-A/10: Method of aiding detection of pancreas cancer.
MB119926 - WO 2019117270-A/128: Method of aiding detection of head and neck cancer.
MB120009 - WO 2019117306-A/31: Method of aiding detection of Alzheimer's disease.
MB119921 - WO 2019117270-A/123: Method of aiding detection of head and neck cancer.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029673
UCSC ID: uc001nku.1
RefSeq Accession: NR_029673

-  Gene Model Information
 
category: noncoding nonsense-mediated-decay: no RNA accession: NR_029673.1
exon count: 1CDS single in 3' UTR: no RNA size: 89
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 204.00frame shift in genome: no % Coverage: 100.00
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.